ANZGOG ASM 2025
CONFERENCE DAY 2 – FRIDAY 7 MARCH – Federation Ballroom
Breakfast Symposium: The role of immunotherapy in cervical cancer Moderator: Yoland Antill
7:15 AM – 8:15 AM
Sponsored by:
QUALITY OF LIFE & SURVIVORSHIP 25 years but 25 long years: Quality of life and survival for people with gynae cancer Session Chairs: Haryana Dhillon, Alison Davis, Bronwyn Jennings, Gwyneth Capes & Jane Power
8:30 AM – 10:20 AM
Speakers
8:30 AM
In the beginning there was quality of life assessment
Michael Friedlander AM
8:45 AM
ANZGOG is the MOST
Rachel Campbell
9:00 AM
Lived experience – Answer the question
TBC
9:10 AM
Are we ever too old for quality of life?
Christopher Steer
9:20 AM
What is the question?
Chindhu Shunmuga Sundaram
9:30 AM
Plenary Discussion
All
Abstract 3: Value of routine pelvic examination in the follow-up of patients receiving adjuvant radiation therapy for endometrial cancer: an Australian tertiary-centre experience
10:00 AM
Matthew Knox
10:10 AM
Abstract 4: Homologous recombination deficiency testing of ascites in ovarian cancer patients
Marta Preston
MORNING TEA – The Atrium and Canberra Room
10:20 AM
UTERINE CANCER Session Chairs: David Chang & Michelle Wilson
10:55 AM – 12:30 PM
Speakers
10:55 AM
Help, I’ve been diagnosed with a rare cancer (patient’s perspective)
Ali Crawford (video)
11:00 AM
Projections: The future of the LMS Landscape
Michelle Harrison
11:15 AM
The impact of molecular characteristics on endometrial cancer
Carien Creutzberg
11:35 AM
Should the surgical paradigms that apply in ovarian cancer apply in endometrial cancer?
Cecile Bergzoll
11:50 AM
Panel discussion
All
Abstract 5: Predicting immunotherapy outcomes in endometrial cancer using multiomic cell-free DNA analysis Abstract 6: C entre of R esearch E xcellence to Improve the Qu ALI ty of Sur V ival in Gynaecological Cancer Pati E nts (CRE ALIVE WELL) LUNCH – The Atrium and Canberra Room Research Advisory Committee (RAC) meeting – Assembly Room
12:10 PM
Lesley Arends
12:20 PM
Eva Baxter
12:30 PM
RECRUITING TRIALS UPDATE Session Chairs: Lois Eva and Paul Cohen
1:25 PM – 2:15 PM
Speakers
1:25 PM 1:30 PM 1:35 PM 1:40 PM 1:45 PM 1:50 PM 1:55 PM 2:00 PM 2:05 PM 2:10 PM
Trial 1 – Ignite Trial 2 – EPOCH
George Au-Yeung Clare Scott AM Alison Brand AM
Trial 3 – Taper
Trial 4 – Domenica
Alison Davis Alison Davis Yoland Antill
Trial 5 – PEACE
Trial 6 – EXPORT42
Trial 7 - ADELE
Linda Mileshkin
Trial 8 – Paragon II
Chee Lee
Trial 9 – ENDO 3 & ANVU
QCGC Collaboration Representative
Q&A
AFTERNOON TEA – The Atrium and Canberra Room
2:15 PM
OVARIAN CANCER Session Chairs: Michael Burling & Cristina Mapagu
2:35 PM – 4:10 PM
Speakers
2:35 PM 2:55 PM 3:05 PM 3:20 PM 3:35 PM 3:50 PM
Racial disparities in the management of ovarian cancer
David Tan
ICON-9 Results Presentation
Linda Mileshkin
Current and emerging treatments in the management of Low-grade serous carcinoma
Cristina Mapagu
Combatting ageism in clinical trials: Is 80 the new 40?
Alison Brand AM
Where to in ovarian cancer research: where to from here?
Elizabeth Christie
Panel discussion
All
4:10 PM – 4:20 PM
Abstract Awards & Close of Conference
Clare Scott AM
4:30 PM
Shuttle Bus departs to Airport
Made with FlippingBook - professional solution for displaying marketing and sales documents online